Hanly, E. K., Tuli, N. Y., Bednarczyk, R. B., Suriano, R., Geliebter, J., Moscatello, A. L., . . . Tiwari, R. K. (2015). Hyperactive ERK and persistent mTOR signaling characterize vemurafenib resistance in papillary thyroid cancer cells. Oncotarget.

Hanly, Elyse K., Neha Y. Tuli, Robert B. Bednarczyk, Robert Suriano, Jan Geliebter, Augustine L. Moscatello, Zbigniew Darzynkiewicz, و Raj K. Tiwari. "Hyperactive ERK and Persistent MTOR Signaling Characterize Vemurafenib Resistance in Papillary Thyroid Cancer Cells." Oncotarget 2015.

Hanly, Elyse K., et al. "Hyperactive ERK and Persistent MTOR Signaling Characterize Vemurafenib Resistance in Papillary Thyroid Cancer Cells." Oncotarget 2015.